These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11027099)

  • 1. [Structural review of chemical agents that can induce parkinsonism].
    Ubeda JV
    Rev Neurol; 2000 Sep 1-15; 31(5):463-8. PubMed ID: 11027099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism in a nursing home: underrecognition.
    Friedman JH; Fernandez HH; Trieschmann MM
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2008 Oct; 40(8):2823-4. PubMed ID: 18929871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can low level exposure to ochratoxin-A cause parkinsonism?
    Sava V; Reunova O; Velasquez A; Sanchez-Ramos J
    J Neurol Sci; 2006 Nov; 249(1):68-75. PubMed ID: 16844142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.
    Okada T; Toichi M; Sakihama M
    J Clin Psychopharmacol; 2003 Oct; 23(5):441-7. PubMed ID: 14520119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism.
    Dajas F; Costa G; Abín-Carriquiry JA; McGregor R; Urbanavicius J
    Funct Neurol; 2001; 16(4 Suppl):113-23. PubMed ID: 11996506
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinsonian signs in subjects with mild cognitive impairment.
    Boyle PA; Wilson RS; Aggarwal NT; Arvanitakis Z; Kelly J; Bienias JL; Bennett DA
    Neurology; 2005 Dec; 65(12):1901-6. PubMed ID: 16380610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caribbean parkinsonism and other atypical parkinsonian disorders.
    Tolosa E; Calandrella D; Gallardo M
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S19-26. PubMed ID: 15109583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the risk of developing parkinsonism following neuroleptic use?
    Noyes K; Liu H; Holloway RG
    Neurology; 2006 Mar; 66(6):941-3. PubMed ID: 16567720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible Parkinsonism linked to trimetazidine.
    Prescrire Int; 2005 Apr; 14(76):63. PubMed ID: 15875344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient parkinsonism: induced by progesterone or pregnancy?
    Demirkiran M; Aslan K; Bicakci S; Bozdemir H; Ozeren A
    Mov Disord; 2004 Nov; 19(11):1382-4. PubMed ID: 15389979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
    Masmoudi K; Gras-Champel V; Masson H; Andréjak M
    Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin-induced parkinsonism.
    Ertan S; Ulu MO; Hanimoglu H; Tanriverdi T; Kafadar AM; Acar ZU; Kiziltan G
    Singapore Med J; 2006 Nov; 47(11):981-3. PubMed ID: 17075669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign tremulous parkinsonism.
    Josephs KA; Matsumoto JY; Ahlskog JE
    Arch Neurol; 2006 Mar; 63(3):354-7. PubMed ID: 16533962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.